Avian Metapneumovirus

Overview, Taxonomy, and Virological Characteristics of Avian Metapneumovirus

Avian metapneumovirus (aMPV) is a highly contagious viral pathogen that poses significant economic challenges to the global poultry industry. Clinically, aMPV is associated with upper respiratory tract infections presenting as severe rhinotracheitis in turkeys and swollen head syndrome in chickens, with secondary bacterial infections frequently compounding the disease severity [1, 8]. The virus has a substantial impact on egg production, growth performance, and overall flock health, making it a primary target for surveillance and control programs as endorsed by international agencies such as the World Organisation for Animal Health (WOAH) and the Food and Agriculture Organization (FAO) [1, 15]. Currently, intensive molecular surveillance further underscores the emerging dynamics of aMPV, especially with new introductions of subtypes A and B into previously aMPV-free regions, revealing both evolutionary adaptations and the complexities of virus epidemiology [5, 6, 14].

Taxonomy

From a taxonomic perspective, aMPV is classified within the family Pneumoviridae and the genus Metapneumovirus. Traditionally, aMPV has been divided into four recognized subtypes, A, B, C, and D, with each subtype displaying distinct genetic, antigenic, and geographic features [1, 11]. While subtypes A and B are widespread and have been historically associated with European and Middle Eastern outbreaks, subtype C has been primarily identified in North America and parts of Asia, and subtype D has also been recorded albeit with less frequency [2, 11]. Recent genomic analyses have even indicated the presence of additional unclassified lineages and divergent strains, highlighting a shifting evolutionary landscape driven by natural selection, host adaptation pressures, and vaccine-induced selective forces [4, 7]. Importantly, the differentiation of subtypes is largely based on variability in the viral glycoprotein (G) gene, with sequence divergence in this region serving as a molecular signature for subtype assignment [3, 11]. Such taxonomic categorizations are essential not only for epidemiological tracking and diagnostic assay design but also for vaccine development and deployment strategies.

The intricate taxonomic structure of aMPV reflects its evolutionary history. Some studies have used full genome sequencing and phylogenetic analyses to demonstrate that despite high genetic similarities within subtypes, often sharing over 99% identity in critical regions, there remain notable nucleotide differences that can be traced back to discrete introduction events and subsequent local evolution [2, 6, 14]. This genetic heterogeneity has important implications for disease management, as vaccine-derived strains and field strains can be distinguished based on their nucleotide and amino acid differences, particularly in the hypervariable regions of the attachment glycoprotein [3, 10]. Such detailed classification continues to be critical for informing biosecurity measures recommended by global health organizations like the Centers for Disease Control and Prevention (CDC) when addressing economically significant viral pathogens.

Virological Characteristics

Avian metapneumovirus is an enveloped, negative-sense single-stranded RNA virus characterized by a non-segmented genome that encodes several structural and nonstructural proteins critical for its replication and pathogenesis [11, 12]. The viral RNA genome is typically organized into eight genes that code for nine proteins, including the nucleoprotein (N), phosphoprotein (P), matrix protein (M), fusion protein (F), M2 proteins (M2-1 and M2-2), small hydrophobic protein (SH), attachment glycoprotein (G), and the large polymerase (L) protein [11]. Among these, the F and G proteins have garnered considerable attention due to their roles in mediating virus entry and cell-to-cell fusion. The F protein facilitates direct membrane fusion between the virus envelope and host cell membrane, an essential step for viral entry, while the G protein is primarily responsible for virus attachment to host cellular receptors [9, 11]. The significant antigenic variability observed in the G protein among different subtypes not only underscores its importance in virus taxonomy but also represents a challenge for the development of universal vaccines [2, 11].

Moreover, the virus exhibits a pleomorphic morphology with surface projections that are primarily composed of G and SH glycoproteins, which contribute to the virus’s ability to attach to and infect host cells. Detailed studies have demonstrated that cellular receptors, such as integrin β1, play a crucial role in the viral entry process by interacting with defined motifs in viral fusion proteins, such as the RSD motif in aMPV subgroup C [9]. This receptor-mediated attachment and the subsequent conformational changes in the viral envelope underscore the virus’s sophisticated mechanism of cell entry and highlight potential targets for antiviral intervention.

At the molecular level, aMPV replication occurs in the cytoplasm of infected cells, where the viral RNA-dependent RNA polymerase complex transcribes the negative-sense RNA genome into individual mRNAs. These mRNAs are then translated into viral proteins, and replication occurs via synthesis of a complementary antigenome, which serves as a template for producing new viral genomes [11, 12]. The coordinated replication process is influenced by host factors and is subject to regulatory mechanisms such as codon usage bias and selective pressure that drive host adaptation. For instance, studies analyzing codon usage in the F gene have provided insights into how selection forces vary across subtypes, further influencing viral adaptation to specific avian hosts like chickens and turkeys [4].

Additionally, the structural organization and molecular interactions of the aMPV proteins modulate the host immune response. The N protein, which encapsidates the viral RNA, is highly immunogenic, making it a prime target for both serological diagnostics and experimental vaccine development [16]. The interplay between viral proteins and the host’s innate immune system is critical; aMPV has evolved mechanisms to counteract host antiviral responses, including the evasion of interferon signaling pathways. For instance, the phosphoprotein (P) of aMPV subgroup C has been shown to inhibit interferon regulatory factor nuclear translocation, thereby suppressing type I interferon production [13]. Such interference with the host's innate defenses allows the virus to establish efficient replication within the upper respiratory tract and is a key factor in its pathogenicity [1, 11].

Overall, the virological characteristics of avian metapneumovirus, including its genome organization, structural protein functions, and interactions with host cell receptors, underscore its dynamic nature as an emerging poultry pathogen. The detailed molecular insights and taxonomic classifications provided by recent studies are instrumental for the development of diagnostic assays and effective vaccination strategies, which are essential for mitigating the economic impact of aMPV on poultry industries worldwide. These advances serve as a foundation for international disease control efforts, supported by guidelines from organizations such as the CDC, WHO, and WOAH.

Molecular Pathogenesis and Host-Virus Interactions in Avian Metapneumovirus Infections

Avian metapneumovirus (aMPV) is an enveloped, negative-sense RNA virus belonging to the Pneumoviridae family, responsible for severe respiratory diseases in poultry and causing significant economic losses worldwide, a concern consistently echoed by global organizations such as the CDC, WHO, and WOAH [1]. The molecular pathogenesis of aMPV involves a highly coordinated interplay between viral structural proteins and a range of host cell factors that govern viral attachment, entry, replication, immune evasion, and ultimately, disease manifestation.

Viral Attachment, Entry, and Receptor Engagement

Central to the initiation of aMPV infection is the engagement of host cell receptors by the viral envelope glycoproteins. The fusion (F) protein, which mediates membrane fusion, is particularly critical for viral entry. Recent studies have underscored the role of integrin β1 (ITGB1) as an essential receptor for aMPV subgroup C, where ITGB1 recognizes a specific fusion protein motif, namely an RSD sequence, facilitating viral attachment and internalization into host cells [9]. In addition to integrin engagement, nucleolin, a multifunctional nucleolar protein, has been identified as a binding partner for the aMPV F protein. This interaction not only promotes efficient viral internalization but also enhances replication once the virus is within the cell [20]. Such receptor-mediated entry mechanisms underscore the sophistication of aMPV’s strategy to exploit ubiquitous cellular molecules, thereby ensuring infection across different avian species.

Interference with Host Innate Immune Responses

Following cell entry, aMPV employs several molecular strategies to subvert the host’s antiviral innate immune response in order to create a favorable environment for replication. One striking mechanism involves the viral phosphoprotein (P). In subgroup C aMPV, the P protein has been demonstrated to selectively inhibit the nuclear translocation of interferon regulatory factor 3 (IRF3), a key transcription factor required for type I interferon production. By preventing IRF3 from reaching the nucleus, the virus effectively dampens the production of interferon β (IFN-β) and the downstream antiviral response [13].

In parallel, aMPV manipulates cellular degradation pathways to neutralize host defense factors. Sequestosome 1 (SQSTM1), a selective autophagic receptor, plays a notable role in this context. Viral replication is attenuated as SQSTM1 mediates the autophagic degradation of the viral M2-2 protein. This degradation not only limits viral replication cycles but also highlights an intricate interplay between autophagy and viral pathogenesis [18]. Moreover, another layer of immune antagonism is provided by the virus-induced degradation of mitochondrial antiviral signaling protein (MAVS). The viral infection triggers K48-linked ubiquitination of MAVS, leading to its degradation via the ubiquitin-proteasome pathway, a mechanism further facilitated by host E3 ubiquitin ligases such as RNF5. This degradation of MAVS, a key adapter in antiviral signaling, disrupts the host’s ability to trigger effective interferon responses, thereby promoting viral survival and propagation [24].

Modulation of Apoptosis and Cellular Stress Responses

Beyond innate immune evasion, aMPV orchestrates alterations in host cell apoptosis pathways. Proteome analyses have revealed that aMPV subtype C infection leads to the upregulation of Polo-like kinase 2 (PLK2), a kinase known to modulate apoptotic cascades. Elevated PLK2 activity correlates with increased reactive oxygen species (ROS) production and subsequent p53-dependent apoptosis. In this way, the virus leverages programmed cell death not only to propagate infection but potentially also to evade immune detection, as apoptotic cell death may limit the presentation of viral antigens and interfere with the activation of specific immune responses [25].

Tissue Tropism and Viral Spread

aMPV exhibits a pronounced tropism for the upper respiratory tract of avian hosts, with a predilection for the tracheal epithelium and associated respiratory tissues such as the nasal turbinates and conjunctiva [19, 22]. Studies using organ culture models have demonstrated that aMPV replicates more efficiently in the oviduct compared to the tracheal epithelium, suggesting that tissue-specific factors and the local immune environment significantly influence viral replication dynamics [19]. In situ hybridization assays have further illustrated the widespread distribution of viral nucleic acids throughout the upper respiratory mucosa, emphasizing the role of localized viral replication and shedding in the transmission dynamics within poultry populations [22].

Genetic Variability and Adaptation

The genetic heterogeneity of aMPV is manifested in its diverse subtypes (A, B, C, and D), and these variations contribute to differences in host-virus interactions. While the core functions of structural proteins such as the F and G glycoproteins remain conserved, minor mutations in these proteins can alter antigenic properties and affect receptor binding affinity. For instance, changes in the glycoprotein’s amino acid sequence may confer a selective advantage by enabling the virus to evade neutralizing antibodies induced by vaccination or previous exposure [4, 6]. Such evolutionary adaptations, driven by host selective pressures, further complicate efforts in designing effective vaccines and necessitate continuous molecular surveillance to track the emergence of novel variants.

Disruption of Cytokine Signaling and Long-Term Persistence

aMPV-induced modulation of cytokine expression is another critical aspect of its molecular pathogenesis. Despite the initial upregulation of cytokines such as interleukins (e.g., IL-6, IL-12) and interferons in response to infection, the virus’s ability to interfere with the downstream signaling pathways eventually blunts the host’s antiviral defense [17]. The dampening of cytokine responses, combined with apoptosis of targeted cells, contributes to both the acute phase of infection and potential persistence of viral particles in the host. In this context, co-infections with bacterial pathogens are not uncommon; the virus-induced immune suppression may create an opportunistic niche for secondary infections that exacerbate disease severity [21].

Insights from Comparative and Experimental Models

Insights into the host-pathogen dynamics of aMPV have been substantially advanced by the use of in vitro models such as primary cell cultures and tracheal organ explants. These models have enabled researchers to dissect how viral proteins interact with host receptors and intracellular signaling molecules. For instance, experiments utilizing chicken tracheal organ cultures have elucidated the strain-dependent differences in virulence between aMPV subtypes and underscored the impact of early immune responses on disease outcomes [19]. Furthermore, reverse genetics systems have been instrumental in mapping the functional domains of viral proteins, thus elucidating the molecular basis for enhanced pathogenicity and immune evasion mechanisms [23].

Collectively, the interplay of these molecular mechanisms and host responses underscores the complexity of aMPV pathogenesis. The virus skillfully manipulates host cellular machinery, from receptor engagement to antiviral signaling inhibition, to establish infection, facilitate viral spread, and overcome host defenses, all while maintaining a high degree of genetic variability that challenges current control strategies [9, 13, 18, 24].

Epidemiology, Geographic Distribution, and Economic Impact of Avian Metapneumovirus

Avian metapneumovirus (aMPV) is recognized as a globally significant pathogen in the poultry industry that causes respiratory and reproductive disorders in its primary hosts, including chickens, turkeys, ducks, and other avian species. The epidemiological profile of aMPV is complex, with fluctuating prevalence patterns influenced by host species, management practices, migratory bird interactions, and regional vaccination strategies. In recent years, the detection of subtypes that were either historically absent or re‐emerging, such as the introduction of subtypes A and B into the United States following decades of apparent absence, has brought renewed urgency to understanding its spread and impact [5, 6, 14]. International agencies such as the World Organisation for Animal Health (WOAH) and the Food and Agriculture Organization (FAO) emphasize the need for rigorous surveillance and biosecurity measures to contain such economically critical avian pathogens.

Epidemiological Dynamics and Host Factors

The epidemiology of aMPV is characterized by rapid spread and variable morbidity across different poultry types. In turkeys, the disease is often associated with acute respiratory distress and raised mortality, especially when compounded by secondary bacterial infections, leading to a condition commonly known as turkey rhinotracheitis. In chickens, while clinical manifestations might be milder, the disorder referred to as swollen head syndrome can result in significant production inefficiencies [1, 3, 30]. Detailed molecular studies have revealed that the viral population is under constant selective pressure, often driven by vaccination practices which can lead to the emergence of vaccine-derived strains as well as field strains with subtle genomic variations [4, 6]. This ongoing genetic diversification is evidenced by a wealth of genomic analyses that show multiple introductions and intra-regional evolution, suggesting that viral adaptation plays a central role in sustaining aMPV in both densely populated commercial operations and in backyard environments [6, 37, 50].

The host species spectrum is notable for its breadth; beyond domesticated poultry, aMPV detection in wild birds, ranging from waterfowl to migratory species, is now well documented [28, 37-39, 41]. Wild birds are implicated as reservoirs and possible transmission vectors, particularly for viral subtypes like aMPV-C, whose high prevalence among mallards and American black ducks has been reported in North America [41, 49]. This wildlife–livestock interface is critical in understanding the epidemiological cycle of aMPV, as migratory birds can introduce new strains into domestic populations, thereby complicating regional control measures [29, 32, 38]. The evidence from Europe, North America, and parts of Asia indicates that environmental and ecological factors such as migratory flyways, local bird population densities, and biosecurity practices in poultry farming all modulate the dynamics of viral spread [7, 43].

Geographic Distribution and Regional Patterns

The geographic spread of aMPV is not uniform, with distinct subtype distributions noted on different continents. In Europe, subtype B predominates, and phylogenetic reconstructions have highlighted both the historical circulation of vaccine-derived strains and the continuous evolution of field strains that tend to cluster by country or even region [7, 43, 44]. In North America, aMPV was long considered a disease of turkey flocks primarily associated with subtype C; however, the recent emergence of subtypes A and B in U.S. flocks has reshaped the epidemiological landscape [5, 14, 30]. These emergent strains are reported to have high genomic identity across various states, suggesting rapid and efficient transmission across commercial operations in key poultry-producing regions such as Pennsylvania, Kentucky, and the Midwest [2, 14, 30].

In Asia, reports from China have documented high genetic similarity among isolates from affected chickens and ducks, with subtype B being isolated from field outbreaks in commercial settings, thus highlighting cross-species transmission events and the potential for unmonitored viral dissemination [26, 27, 45]. Additionally, serological and molecular surveillance in tropical regions like Nigeria and Bangladesh has detected aMPV antibodies and viral RNA frequently in commercial flocks, indicating that climatic stressors and high-density rearing practices contribute to seasonal outbreaks and persistent endemicity in these regions [46, 48]. Moreover, investigations in the Middle East and North Africa underscore a scenario where inadequate biosecurity and limited surveillance infrastructure have allowed the virus to circulate relatively unchecked, further underlining the transboundary nature of aMPV infections [42, 50].

Economic Impact on the Poultry Industry

The economic repercussions of aMPV extend far beyond the immediate costs of mortality and decreased productivity. Outbreaks typically lead to reduced feed conversion ratios, diminished egg production, and significant producer losses due to increased veterinary costs and the need for enhanced biosecurity. In turkeys, the rapid progression of clinical disease often results in high mortality rates and the necessity to cull affected flocks, while in chickens, the prolonged drop in egg production can directly affect revenue streams in layer operations [1, 8, 30, 47]. Studies have shown that co-infections, especially with bacteria such as Escherichia coli and pathogens like Ornithobacterium rhinotracheale, exacerbate the clinical picture, leading to compounded losses in production efficiency and increased reliance on antimicrobial treatments [21, 30, 35]. These secondary infections not only complicate clinical management but also heighten the risk of antibiotic resistance, a growing concern that resonates with global public health and agricultural authorities such as the Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO).

The economic impact is further influenced by regional differences in vaccination strategies and disease management protocols. For instance, in areas where robust vaccination programs have been implemented, the economic losses may be mitigated, yet the emergence of vaccine-derived strains poses additional challenges that necessitate ongoing genomic surveillance and vaccine updates [4, 10, 34]. In contrast, regions with limited vaccine coverage and suboptimal biosecurity, such as several developing countries, experience more severe outbreaks with higher associated economic burdens [46, 48]. International organizations like the FAO and WOAH routinely emphasize the importance of harmonized diagnostic and control strategies, underscoring that effective vaccination, coupled with prompt field detection methods, is critical for reducing the overall economic impact of aMPV [1, 33].

The interplay between viral evolution and economic impact is multifaceted. The rapid spread of newly emerged subtypes in previously aMPV-free regions not only disrupts local poultry markets but also challenges existing trade barriers and export certifications, thereby affecting international poultry commerce. Continuous high-throughput surveillance, including advanced molecular methods such as multiplex RT-qPCR and next-generation sequencing, is crucial for early detection and containment of aMPV outbreaks, ensuring that economic losses are minimized while maintaining high animal welfare standards [31, 36, 40]. This integrated approach to disease surveillance and management is essential for sustaining the global poultry industry, which is a significant contributor to food security and economic growth worldwide, as recognized by the CDC, WHO, FAO, and WOAH.

Diagnostic Approaches, Isolation Techniques, and Molecular Characterization of Avian Metapneumovirus

Avian metapneumovirus (aMPV) represents one of the most economically important viral respiratory pathogens in poultry. Given its capacity to cause upper respiratory syndromes in chickens and turkeys, with significant implications recognized by major organizations such as the CDC, WHO, and WOAH, it is critical to implement robust diagnostic and isolation protocols alongside molecular characterization methods that shed light on its evolution and epidemiology [1, 56]. Researchers have developed a diverse toolkit based on molecular, serological, and cell culture methodologies that allow for in‐depth investigation of aMPV in field samples.

Diagnostic Approaches Using Molecular and Serological Techniques

The cornerstone for aMPV diagnosis in modern veterinary laboratories is molecular detection, particularly through reverse-transcription polymerase chain reaction (RT-PCR) and its quantitative variant (RT-qPCR). Multiplex real-time RT-PCR assays have been developed to simultaneously detect and differentiate aMPV subtypes, thereby enabling high-throughput screening and accurate subtype assignment [10, 53]. The sensitivity of these assays can reach very low copy numbers, allowing detection of as few as 10 copies per reaction in field samples [10, 31]. Such sensitivity is critical when monitoring flocks that may harbor low viral loads during early infections.

Additional diagnostic innovations include recombinase-aided amplification (RAA) and loop-mediated isothermal amplification (RT-LAMP) combined with DNA-functionalized gold nanoparticle probes. These methods provide rapid detection capabilities on a field basis, with results achievable within one hour and minimal equipment requirements, factors particularly valuable for on-site epidemiological surveillance in remote or resource-limited settings [31, 52, 54]. In tandem with nucleic acid-based approaches, serological assays, including ELISA techniques using recombinant nucleocapsid proteins, have enhanced the capacity to monitor immune responses and evaluate vaccine efficacy. Such recombinant protein–based assays not only offer high sensitivity and specificity but also permit simultaneous detection of antibodies produced against multiple aMPV subtypes [16]. The integration of these diagnostic modalities ensures that laboratories can comprehensively monitor virus circulation in commercial as well as backyard poultry populations [35, 57].

Notably, innovative field detection platforms that combine isothermal pre-amplification with CRISPR-Cas13a have recently demonstrated improved sensitivity and specificity compared to conventional RT-PCR methods. These platforms eliminate the dependence on sophisticated instrumentation, thereby reducing turnaround time and operational complexity [31]. The development of digital droplet RT-PCR (ddRT-PCR) methods targeting conserved regions within the viral genome, such as the polymerase gene, has further refined the detection and quantification processes by partitioning reaction mixtures to provide absolute quantification of rare target molecules [40]. Such advancements underscore the continuous evolution of diagnostic strategies for this economically critical pathogen as endorsed by entities like WOAH.

Isolation Techniques and In Vitro Propagation

The isolation of aMPV from clinical specimens remains a fundamental step not only for diagnostic confirmation but also for the in-depth molecular characterization and vaccine development processes. Traditional isolation techniques involve the inoculation of suspected clinical samples into specific-pathogen-free embryonated chicken eggs or primary cell cultures derived from chicken embryonic tissues [2, 26]. For example, primary chicken embryo lung or fibroblast cells have proven effective for recovering virus isolates, particularly for subtypes A and B [2]. Following initial isolation, aMPV strains are often adapted in continuous cell lines such as Vero cells, where serial passaging results in enhanced viral titers and allows for the observation of genetic changes that occur during domestication in cell culture [2, 27]. This adaptation process is crucial since mutations acquired during in vitro propagation can subsequently inform studies on virulence determinants, immune evasion mechanisms, and potential vaccine strain reversion events.

Advanced isolation methods include the use of organ culture systems, where respiratory tract explants maintain a more natural cellular architecture. These techniques replicate in vivo tissue responses and provide insights into viral tropism and the kinetics of replication at the cellular level [19, 51]. In addition to conventional cytopathic effect observation, immunofluorescence and western blotting using specific anti-viral antibodies are routinely employed to confirm virus identity during and after isolation [17, 26]. Such multi-faceted isolation techniques strengthen diagnostic reliability and facilitate subsequent molecular analyses.

Molecular Characterization and Genomic Insights

Detailed molecular characterization of aMPV is essential for understanding its genetic diversity, pathogenicity, and evolutionary dynamics. A prevalent strategy involves sequencing of the attachment (G) gene, which is known for its high variability and sensitivity to selective pressures. Phylogenetic analysis of G gene sequences has provided extraordinary insights into the epidemiologic dynamics of aMPV, including the identification of multiple lineages within subtypes and the discernment between vaccine-derived and field strains [3, 6, 43]. For instance, recent studies have demonstrated clonal expansion events and regional clustering patterns among aMPV-B isolates, which are critical for tailoring vaccination programs and biosecurity measures [3, 6].

Whole-genome sequencing approaches, particularly those based on next-generation sequencing (NGS) technologies, have further revolutionized aMPV molecular characterization. Multiplex tiling RT-PCR methods allow for the direct sequencing of complete aMPV genomes from clinical samples, even in the context of low viral loads [36]. Such approaches facilitate the identification of nucleotide substitutions, insertions, or deletions that may be associated with altered virulence or host adaptation [4]. Comparative genomic analyses have shed light on the evolutionary trajectories of distinct aMPV subtypes and have allowed researchers to detect minor genetic variations, such as single nucleotide polymorphisms (SNPs) and amino acid mutations, that can differentiate field strains from attenuated vaccine strains [4, 6].

Another layer of molecular characterization involves the study of viral protein functions using reverse genetics systems. These systems enable the generation of recombinant viruses with specific gene modifications, thus facilitating mechanistic studies of individual viral proteins such as the fusion (F) protein, which plays a dominant role in viral entry and cell fusion [9, 55]. Moreover, such systems are instrumental in evaluating the impact of gene truncations on virus replication, virulence, and the subsequent activation of host immune responses by measuring changes in cytokine and interferon profiles post-infection [17, 51].

An emerging area of research focuses on assessing the interplay between aMPV and host cellular factors. For example, studies have demonstrated that selective autophagic receptors and proteins like SQSTM1 can directly impact viral replication via degradation of viral regulatory proteins [18]. Similarly, host factors involved in the innate immune response, such as interferon regulatory factors (IRF3 and IRF7), have been shown to interact with aMPV proteins to modulate interferon responses, thereby providing insights into viral immune evasion strategies [13]. These advanced molecular techniques not only contribute to a more comprehensive understanding of aMPV pathogenesis but also guide the design of next-generation vaccines and antiviral therapies.

Collectively, the multifaceted diagnostic methods, refined isolation techniques, and in-depth molecular characterization processes have advanced our understanding of aMPV biology. The combination of sensitive nucleic acid detection assays, robust cell culture isolation protocols, and high-resolution genomic sequencing provides a framework that is consistent with international best practices as recommended by agencies such as the WOAH, CDC, and FAO, thereby contributing to effective surveillance and control of this pathogen in commercial and backyard poultry operations.

Genetic Diversity, Subtype Classification, and Molecular Evolution of Avian Metapneumovirus

Avian metapneumovirus (aMPV) has emerged as one of the most critical respiratory pathogens affecting poultry around the globe. Its genetic diversity, complex subtype classification, and rapid molecular evolution pose significant challenges and opportunities for both disease control and vaccine development. The virus is currently classified into four recognized subtypes, A, B, C, and D, with additional divergent lineages and unclassified variants now being reported in various wild and domestic avian hosts [1, 4]. High-throughput molecular techniques coupled with next-generation sequencing have enabled detailed analyses of genomic variability across isolates from different continents, thereby enriching our understanding of its epidemiological dynamics.

Genetic Diversity in Avian Metapneumovirus

The genetic diversity of aMPV is primarily driven by mutations in key viral proteins, including the attachment glycoprotein (G) and fusion (F) proteins. These proteins are important not only for viral entry and host specificity but also act as targets for the host immune response. Comparative analyses of full-genome sequences have highlighted that divergence within the G gene, in particular, underlies the antigenic variability observed among subtypes [2, 4]. For instance, isolates from recent United States outbreaks have demonstrated substantial nucleotide variability (with >99% intra-subtype identity yet distinctive amino acid substitutions) that may have resulted from localized viral spread and selective pressure from vaccination protocols [2, 6]. In parallel, studies on isolates from Asia and Europe have revealed that even within a single subtype, such as subtype B, there is evidence of multiple independent introduction and subsequent local evolution events, leading to heterogeneous populations within flocks and vast geographic disparities [3, 43]. This scenario is reminiscent of other economically significant viral pathogens monitored by international bodies such as the Centers for Disease Control (CDC) and the World Organisation for Animal Health (WOAH), emphasizing the profound impact of viral evolution on disease outbreaks and vaccine efficacy.

Subtype Classification and Epidemiological Insights

Subtype classification of aMPV is based on both genomic sequences and antigenic properties, with the four major subtypes initially defined via differences in the G gene and other structural proteins [1]. Subtypes A and B have long been associated with the Old World and are now emerging in North America, where their incursion in early 2024 has raised pressing questions regarding their introduction routes and epidemiological impact [2, 5]. Molecular phylogenetic analyses indicate that subtype A in the United States is genetically related to strains previously circulating in Mexico and possibly Asia, while subtype B exhibits close evolutionary relationships with Eastern Asian and European isolates, suggesting wild bird migration and live bird trade as contributing factors [3, 5, 32]. Furthermore, subtype C, first isolated from severe respiratory outbreaks in China, appears to have a broad host range with less geographic restriction; its widespread emergence in both wild ducks and poultry highlights a potential reservoir role for migratory birds [26, 29, 41]. Subtype D remains less well characterized, although its detection reinforces the viral heterogeneity that challenges current diagnostic and control strategies.

Beyond the classical subtypes, recent studies employing multiplex RT-qPCR and digital droplet PCR have improved the resolution of subtype differentiation, ensuring that subtle genomic differences are captured even when genetic drift is minimal [10, 40]. Codon usage bias analyses have further demonstrated that adaptive selection pressures, largely driven by host immune responses and vaccination practices, can shape the genetic composition of the virus, particularly in genes critical for host-cell interaction such as the F glycoprotein [4]. This degree of molecular refinement not only aids in unambiguous subtype assignment but also elevates our understanding of the interplay between viral evolution and epidemiological outcomes.

Molecular Evolution Mechanisms and Adaptive Strategies

Molecular evolution in aMPV is the cumulative result of mutations, recombination events, and selective pressures imposed by host immunity and vaccination. The selective pressure on the G gene results in amino acid substitutions that may alter antigenic sites, thereby influencing neutralization efficacy of antibodies and complicating vaccine design [3, 4]. For example, single point mutations such as the substitution at position 153 in some US subtype B isolates have been noted to distinguish strains isolated from different poultry species, hinting at host-specific adaptation mechanisms [3]. Additionally, evolutionary analyses using Bayesian frameworks have estimated divergence times and have mapped out the expansion of sub-lineages within specific geographic contexts, suggesting that aMPV’s spread may follow dynamic and region-specific evolutionary trajectories [29, 32].

The interplay between vaccine-driven immunity and viral evolution represents a particularly critical aspect of aMPV molecular evolution. In several studies, isolates adapted through serial passages in cell culture were shown to acquire nucleotide changes over time, highlighting the capacity for rapid phenotypic shifts even under controlled conditions [2, 27]. Such findings draw parallels with other viral pathogens monitored by agencies like the FAO, where vaccine escape and antigenic drift can fundamentally alter the epidemiological landscape. Moreover, codon usage analyses have provided evidence that subtypes B and C, in particular, experience stronger selective constraints, indicative of ongoing pressure to optimize viral replication in specific hosts [4]. These adaptive strategies underscore the dynamic nature of aMPV evolution and its potential to emerge as a significant challenge for global poultry health.

Evolutionary studies have also underscored the possibility of multiple independent introduction events into certain regions, leading to a mosaic of genetic variants within a single country [6, 58]. Such mosaicism not only complicates outbreak tracking but also necessitates robust molecular surveillance systems. International organizations such as the CDC and WOAH advocate for vigilant viral genomic monitoring, especially for pathogens that pose significant economic threats to the poultry industry. This surveillance is essential for timely updates to diagnostic assays and vaccines, ensuring they reflect the current circulating strains.

The evolutionary plasticity of aMPV, as evidenced by the continuous accumulation of single nucleotide polymorphisms and occasional larger genetic shifts, further implies that long-term control strategies must consider aMPV as a moving target that adapts in response to both natural and artificial selection pressures [5, 27]. This observation accentuates the importance of integrating molecular epidemiology with field surveillance to tailor vaccination programs that can mitigate the impact of emerging variants while maintaining broad-spectrum efficacy, a challenge currently shared with many respiratory pathogens of global economic and public health importance.

Through the lens of genomic diversity, subtype differentiation, and adaptive evolution, aMPV exemplifies a dynamic viral pathogen that continues to evolve in response to both host and external environmental pressures. Its ability to undergo rapid mutation and adaptation reinforces the need for integrated molecular surveillance and agile vaccine strategies endorsed by global regulatory bodies such as the CDC, WHO, and WOAH.

Transmission Dynamics in Poultry

Avian metapneumovirus (aMPV) establishes infection primarily through the respiratory tract, exploiting the close contact and high stocking densities typical of commercial poultry operations. The virus is shed in respiratory secretions and spreads rapidly via aerosol droplets and direct contact between birds. In densely populated flocks, these transmission routes facilitate a near-exponential spread, especially in production systems where birds share ventilation and housing systems. Molecular investigations have highlighted the role of the attachment glycoprotein (G) and fusion (F) proteins in mediating viral entry into host cells, further emphasizing how these structural proteins determine tissue tropism and inter-host spread [1, 4, 28]. As noted by global health organizations such as the CDC and FAO, respiratory pathogens with these transmission characteristics can lead to rapid outbreaks with significant economic consequences [WHO, FAO].

The efficient horizontal transmission of aMPV is enhanced by the virus’s capacity to infect the upper respiratory system, where its replication disrupts the integrity of the mucosal barrier and ciliary function. This impairment not only facilitates further dissemination within the flock but also predisposes birds to secondary opportunistic infections [30]. Studies have demonstrated virus propagation in both chickens and turkeys, with evidence that even low titers of virus can result in noticeable clinical symptoms and eventual outbreak clusters if biosecurity measures are insufficient [2, 8]. Furthermore, instances of aMPV spillover from vaccinated poultry to wild birds, and vice versa, have been documented. Phylogenetic analyses reveal a close genetic relationship between strains circulating in commercial flocks and those detected in wild waterfowl, suggesting complex interspecies transmission dynamics at the domestic–wild bird interface [28, 32].

Biological Mechanisms Underpinning Transmission

At a molecular level, aMPV utilizes conserved binding motifs in the F and G proteins to attach to and infect host cells, particularly targeting respiratory epithelial cells. These proteins are subject to continuous evolutionary pressures that can facilitate adaptation to different host species and environmental conditions, and drive viral gene flow between geographically separated populations [4, 32]. Moreover, viral replication in the respiratory epithelium can induce local inflammation and tissue lesions, contributing to visible clinical signs such as swollen head syndrome in chickens and turkey rhinotracheitis in turkeys [8, 30]. Cellular studies have also demonstrated that aMPV infection may interfere with innate immune responses, thereby allowing the virus to evade early host defenses and establish a more robust infection [13, 17]. Such mechanisms underlie the virus’s ability to cause widespread outbreaks, especially when compounded with external stressors found in high-density production environments.

Co-infections and Their Impact on Disease Dynamics

Co-infections represent a significant complicating factor in the epidemiology of aMPV. In poultry production, aMPV rarely acts in isolation. Instead, it frequently co-circulates with bacterial pathogens such as Escherichia coli, Ornithobacterium rhinotracheale, and other respiratory agents like Infectious Bronchitis Virus (IBV) and Avibacterium paragallinarum [19, 30]. These concurrent infections can exacerbate disease severity by further compromising respiratory defense mechanisms and precipitating secondary bacterial diseases that are harder to control with routine antibiotic treatment. Studies have documented that co-infection cases often show a higher rate of morbidity and mortality, leading to severe clinical presentations and marked declines in productivity [30, 59].

The synergy between aMPV and bacterial co-pathogens is particularly concerning. For instance, the presence of aMPV has been associated with an increased incidence of colibacillosis in broilers, as the viral-induced damage to the respiratory epithelium creates an entry point for opportunistic bacteria [8]. In turkeys, similar patterns are observed with secondary infections of Ornithobacterium rhinotracheale, which further devastate flock health by intensifying respiratory symptoms [30]. In vitro studies have provided insights into how sequential infections can modulate immune responses, suggesting that prior aMPV infection might alter the immune landscape of the respiratory tract rendering birds more susceptible later to bacterial invasion [21]. Additionally, dual infections involving aMPV and IBV complicate the clinical picture and challenge conventional diagnostic and vaccination strategies, necessitating a comprehensive approach to disease management that addresses multiple pathogens simultaneously [40, 53].

Disease Outbreaks in Poultry

Outbreaks of aMPV in poultry often occur in the context of suboptimal biosecurity practices and high animal density, conditions that are common in intensive farming systems. The rapid dissemination of aMPV subtypes A and B in the United States since their recent detection underscores a dynamic epidemiological landscape. Outbreak investigations based on molecular assays have demonstrated that aMPV subtypes A and B can rapidly spread across geographical regions, affecting multiple species, with turkeys generally exhibiting more pronounced clinical symptoms compared to chickens [2, 6, 8]. These outbreaks are characterized by significant respiratory disease, reduced egg production, and high economic losses. In regions where aMPV was previously controlled or undetected, the re-emergence or introduction of new viral subtypes has led to widespread disease, illustrating how persistent viral circulation combined with sporadic introduction events can challenge existing control strategies [5, 14, 30].

The role of wild birds in initiating and perpetuating outbreaks cannot be understated. Migratory waterfowl often serve as reservoirs for aMPV, as detected in studies that have revealed a high prevalence of aMPV in wild duck populations, indicating their potential as sources for viral spillover [28, 32]. Moreover, these wild bird populations, moving along established migratory pathways, may facilitate long-distance dissemination of the virus, posing ongoing challenges to regional and international poultry health management efforts. Outbreaks linked to these transmission cycles have prompted concerted surveillance efforts by governmental bodies such as the WOAH and regional health authorities, who stress the importance of stringent monitoring and coordinated biosecurity measures to mitigate disease spread [CDC, WOAH].

From an epidemiological standpoint, the periodic cyclic nature of aMPV outbreaks is influenced by host immunity, environmental factors, and the emergence of new viral variants. Recent phylodynamic reconstructions have revealed that distinct viral clusters can be attributed to localized expansion events following introduction from external sources. Such findings stress the benefits of region-specific interventions, including targeted vaccination strategies and enhanced biosecurity practices that are essential in containing outbreaks once initial cases are detected [6, 30, 32]. In sum, the intersection of rapid viral transmission, complex co-infection dynamics, and challenging outbreak scenarios defines the current epidemiological profile of aMPV in poultry, necessitating an integrated approach to disease surveillance and control informed by molecular, environmental, and host-specific factors.

Control Strategies in Avian Metapneumovirus Management

Avian metapneumovirus (aMPV) poses a significant threat to poultry production worldwide, making control strategies an essential component of disease management. Current control measures extend beyond mere clinical recognition, involving rigorous biosecurity protocols, enhanced diagnostic surveillance, and targeted eradication efforts in affected populations. In regions where aMPV outbreaks have been documented, producers have been encouraged to adopt strict biosecurity measures, ranging from controlled access to housing facilities to routine cleaning and disinfection protocols, in order to reduce the risk of virus spread both within flocks and across neighboring productions [1, 30]. In addition, the absence of evidence for vertical transmission, as demonstrated by the lack of viral RNA in egg samples from infected commercial turkey breeders [60], underscores the importance of controlling the horizontal spread of the virus through improved farm management practices.

The implementation of advanced molecular diagnostic tools is central to these control strategies. Emerging technologies, such as multiplex RT-qPCR assays and CRISPR-Cas13a integrated detection systems, provide rapid and highly sensitive means for virus detection and subtyping [10, 31, 53]. These diagnostic platforms, when combined with comprehensive epidemiological surveillance, allow for early identification of outbreaks and help inform targeted interventions. There is also increasing reliance on next-generation sequencing to track viral evolution and identify potential vaccine escape mutants, ensuring that control strategies remain relevant despite the high genetic variability of circulating aMPV strains [2, 6, 36]. Worldwide organizations such as the CDC, WHO, WOAH, and FAO underscore that such integrated control approaches are critical to preventing economic losses in the poultry industry and safeguarding food security.

Vaccination Approaches

Vaccination strategies against aMPV have evolved considerably over recent years. Early efforts focused on live attenuated vaccines that were designed to provide robust protection by mimicking natural infections. For instance, studies have demonstrated that live aMPV subtype B vaccines developed following serial passaging in cell cultures not only yielded attenuated viral strains but also induced strong humoral immune responses and cross-protection against both homologous and heterologous challenge viruses [27]. Modified live vaccines have been conveniently administered through mass vaccination techniques, including drinking water or spraying, thus ensuring practicality in high-density commercial operations.

Alongside live vaccines, inactivated vaccine formulations have been explored, particularly in regions where vaccine safety is paramount. An inactivated aMPV/B vaccine candidate has shown promising results in stimulating both humoral and cellular immune responses, with evidence of sustained protection and reduced virus shedding over extended periods [62]. The use of novel adjuvants, including immune-stimulating complexes (ISCOMs), further enhances the immunogenicity of these formulations, suggesting that a balanced activation of Th1/Th2 responses may be critical for long-term protection.

In addition to conventional approaches, recombinant vaccine strategies are emerging as a next-generation option. Recombinant aMPV/C expressing heterologous antigens such as the HA protein of H9N2 avian influenza virus has been successfully generated, showing stable gene expression and effective protection in experimental models [55]. These recombinant vaccines not only serve a dual purpose by protecting against multiple pathogens but also demonstrate the potential for modular vaccine designs that can be tailored to regional viral genotypes. Furthermore, combining vaccination protocols to address co-circulating pathogens has also been investigated. For instance, the simultaneous administration of live vaccines against Newcastle disease virus and aMPV to day-old turkeys, a strategy that enhances operational efficiency in hatcheries, has been shown to confer protective immunity against both agents without interference [61].

Despite these advancements, the immune response elicited by aMPV vaccination, particularly in commercial settings, often varies by bird age, viral load, and host factors. Recent studies have highlighted that while antibody responses can be robust, even low titers may correlate with clinical protection, suggesting that cellular immunity and innate responses are possibly more critical determinants of vaccine efficacy [27, 47]. Alternative methods to assess vaccine efficacy, such as evaluating tracheal ciliary activity after challenge infection, offer additional layers of evidence to refine vaccination regimens [51]. In this context, improving vaccine formulations to elicit a broader spectrum of responses, potentially including cell-mediated immunity, is a priority that could be achieved through adjuvant optimization or recombinant vector platforms.

Future Directions in Avian Metapneumovirus Research

The future of aMPV control lies at the intersection of advanced genomic technologies, improved understanding of host–pathogen interactions, and innovative vaccination platforms. Molecular epidemiological studies using complete genome sequencing have already provided insights into the complex transmission dynamics and rapid evolution of aMPV in different regions [6, 36]. These insights are critical for monitoring vaccine effectiveness over time, as selective pressures, possibly driven by widespread vaccination, may lead to the emergence of novel variants with altered antigenicity [4]. Future research efforts will require continuous genomic surveillance to detect minor nucleotide changes that may have significant immunological implications.

Another promising area is the exploration of viral-host interactions at the molecular level. Detailed investigations into how aMPV proteins interact with host cell factors, such as the role of specific viral glycoprotein mutations in immune evasion, and the impact of viral interference with innate immune signaling pathways provide the groundwork for designing next-generation vaccines and antiviral agents [4, 13]. The development and application of in vitro and ex vivo organ culture models are particularly encouraging, as these models allow controlled studies of viral replication and pathogenesis while maintaining a close approximation to the in vivo environment [19, 23].

In addition, given aMPV’s capacity for cross-species transmission and the demonstrated role of wild birds as reservoirs, future directions will likely include expanding surveillance efforts at the wildlife-domestic interface [28, 37]. Integrating data from wild birds with those from commercial poultry via coordinated monitoring programs, supported by FAO and WOAH guidelines, could provide early warnings of outbreak potential and improve biosecurity protocols across geographical regions.

Innovative diagnostic methodologies are equally poised to transform aMPV research and control strategies. The advent of digital droplet RT-PCR techniques, next-generation sequencing, and portable field-deployable diagnostic kits has the potential to deliver rapid, cost-effective, and ultra-sensitive detection of aMPV subtypes directly on farm premises [31, 40]. Such tools not only enhance our ability to track outbreaks in real time but also provide critical information for tailoring regional vaccination strategies.

Finally, the combination of vaccination deployment and molecular surveillance will be central to global aMPV control efforts. Cross-disciplinary collaborations among veterinary researchers, epidemiologists, and immunologists, along with support from global health and agricultural organizations such as the CDC, WHO, and WOAH, will help drive the optimization of vaccination protocols and enable rapid responses to emerging viral variants. This integrated approach is critical for minimizing economic losses, sustaining poultry production, and ensuring comprehensive disease control in an increasingly interconnected world.

References

[1] Mo J, Mo J. Infectious Laryngotracheitis Virus and Avian Metapneumovirus: A Comprehensive Review. Pathogens. 2025. DOI: https://doi.org/10.3390/pathogens14010055

[2] Zhang J, Tian L, Dittman JD, Guo B, Kimpston-Burkgren K, Kalkwarf E, et al.. Isolation and characterization of avian metapneumovirus subtypes A and B associated with the 2024 disease outbreaks among poultry in the USA. Journal of Clinical Microbiology. 2025. DOI: https://doi.org/10.1128/jcm.00333-25

[3] Luqman M, Duhan N, Temeeyasen G, Selim MH, Jangra S, Mor S. Geographical Expansion of Avian Metapneumovirus Subtype B: First Detection and Molecular Characterization of Avian Metapneumovirus Subtype B in US Poultry. Viruses. 2024. DOI: https://doi.org/10.3390/v16040508

[4] Shi S, Gao J, Gai M, Pan Y, Cao J, Peng T, et al.. Comparative analysis of codon usage bias and host adaptation across avian metapneumovirus genotypes. Poultry Science. 2025. DOI: https://doi.org/10.1016/j.psj.2025.105428

[5] Goraichuk I, Torchetti M, Killian M, Kapczynski D, Sary K, Kulkarni A, et al.. Introduction of Avian metapneumovirus subtype A to the United States: molecular insights and implications. Frontiers in Microbiology. 2024. DOI: https://doi.org/10.3389/fmicb.2024.1428248

[6] Álvarez-Narváez S, Sary K, Goraichuk I, Kulkarni A, Kapczynski D, Suarez DL. Genetic Diversity of Recent U.S. Avian Metapneumovirus Subtype B Viruses Suggests Separate Incursions into Commercial Poultry Flocks.. Avian diseases. 2025. DOI: https://doi.org/10.1637/aviandiseases-d-25-00088

[7] Zekhnini H, Salam MR, Mellouli F, Fellahi S, Ezaouine A, Bennis F, et al.. Phylogenetic Insights and Host-Specific Dynamics of Avian Metapneumovirus in Moroccan Wild Birds.. Avian diseases. 2025. DOI: https://doi.org/10.1637/aviandiseases-d-25-00018

[8] Nguyen V, Ramsubeik S, Jerry CF, Crossley B, Churria CDG, Jackson W, et al.. Avian Metapneumovirus Subtype A Infection in Commercial Chickens (Gallus gallus domesticus) and Turkeys (Meleagris gallopavo) in California.. Avian diseases. 2025. DOI: https://doi.org/10.1637/aviandiseases-d-24-00059

[9] Cui Y, Li S, Xu W, Li Y, Xie J, Wang D, et al.. A Receptor Integrin β1 Promotes Infection of Avian Metapneumovirus Subgroup C by Recognizing a Viral Fusion Protein RSD Motif. International Journal of Molecular Sciences. 2024. DOI: https://doi.org/10.3390/ijms25020829

[10] Su M, Cheng J, Xu X, Liu Y, Zhao Y, Wang Y, et al.. Establishment and application of a one-step multiplex real-time PCR assay for detection of A, B, and C subtypes of avian metapneumovirus. Poultry Science. 2024. DOI: https://doi.org/10.1016/j.psj.2024.104608

[11] Abgaryan SR, Pankratov SV, Semina AN. Diagnosis of avian metapneumovirus infection using multiplex PCR. Legal regulation in veterinary medicine. 2023. DOI: https://doi.org/10.52419/issn2782-6252.2022.4.42

[12] . avian metapneumovirus. CABI Compendium. 2022. DOI: https://doi.org/10.1079/cabicompendium.92920

[13] Hou L, Shi Y, Guo J, Sun T, Wang D, Yang X, et al.. Avian Metapneumovirus Subgroup C Phosphoprotein Suppresses Type I Interferon Production by Blocking Interferon Regulatory Factor 3 Nuclear Translocation. Microbiology spectrum. 2022. DOI: https://doi.org/10.1128/spectrum.03413-22

[14] Selim MH, Jangra S, Luqman M, Clement T, Duhan N, Temeeyasen G, et al.. Tracking the Virus Spread and Evolution of Emerging Avian Metapneumovirus Subtypes A and B in U.S. Poultry.. Avian diseases. 2026. DOI: https://doi.org/10.1637/aviandiseases-d-25-00072

[15] Hatfield JS, Thielen B, Goyal S. Avian Metapneumovirus: Virology, Epidemiology, and Insights from a Comparative Analysis with Human Metapneumovirus, A Review. Biomolecules. 2026. DOI: https://doi.org/10.3390/biom16030351

[16] Xu W, Suderman M, Koziuk J, Ojkić D, Berhane Y. Development of A recombinant nucleocapsid based indirect ELISA for the detection of antibodies to avian metapneumovirus subtypes, A, B, and C.. Veterinary Immunology and Immunopathology. 2020. DOI: https://doi.org/10.1016/j.vetimm.2020.110151

[17] Hong S, Ha E, Kim H, Kim S, Ahn S, An S, et al.. Effects of G and SH Truncation on the Replication, Virulence, and Immunogenicity of Avian Metapneumovirus. Vaccines. 2024. DOI: https://doi.org/10.3390/vaccines12010106

[18] Guo J, Shi Y, Jiang G, Zeng P, Wu Z, Wang D, et al.. SQSTM1 downregulates avian metapneumovirus subgroup C replication via mediating selective autophagic degradation of viral M2-2 protein. Journal of Virology. 2024. DOI: https://doi.org/10.1128/jvi.00051-24

[19] Bexter F, Rüger N, Sid H, Herbst A, Gabriel G, Osterhaus A, et al.. In Vitro Investigation of the Interaction of Avian Metapneumovirus and Newcastle Disease Virus with Turkey Respiratory and Reproductive Tissue. Viruses. 2023. DOI: https://doi.org/10.3390/v15040907

[20] Wang D, Hou L, Zhu N, Yang X, Zhou J, Cui Y, et al.. Interaction of Nucleolin with the Fusion Protein of Avian Metapneumovirus Subgroup C Contributes to Viral Replication. Viruses. 2022. DOI: https://doi.org/10.3390/v14071402

[21] Rüger N, Sid H, Meens J, Szostak M, Baumgärtner W, Bexter F, et al.. New Insights into the Host–Pathogen Interaction of Mycoplasma gallisepticum and Avian Metapneumovirus in Tracheal Organ Cultures of Chicken. Microorganisms. 2021. DOI: https://doi.org/10.3390/microorganisms9112407

[22] Abosria KH, Clontz D, Selim MH, Bashir N, Knudsen D, Hoerr F, et al.. In situ Hybridization to Study the Pathogenicity of North American Avian Metapneumovirus Subtypes A and B in Turkeys.. Avian diseases. 2026. DOI: https://doi.org/10.1637/aviandiseases-d-25-00070

[23] Körner L, Morito HLE, Ludlow M, Rautenschlein S. In vitro Models and Molecular Tools for Investigation of Avian Metapneumovirus-Host Interactions.. Avian diseases. 2026. DOI: https://doi.org/10.1637/aviandiseases-d-25-00092

[24] Hou L, Hu X, Guo J, Quan R, Wei L, Wang J, et al.. Avian Metapneumovirus Subgroup C Induces Mitochondrial Antiviral Signaling Protein Degradation through the Ubiquitin-Proteasome Pathway. Viruses. 2021. DOI: https://doi.org/10.3390/v13101990

[25] Quan R, Wei L, Hou L, Wang J, Zhu S, Li Z, et al.. Proteome Analysis in a Mammalian Cell Line Reveals that PLK2 Is Involved in Avian Metapneumovirus Type C (aMPV/C)-Induced Apoptosis. Viruses. 2020. DOI: https://doi.org/10.3390/v12040375

[26] Yao Z, Li J, Shi Y, Sun T, Yang X, Mao J, et al.. Isolation and identification of a subtype C avian metapneumovirus in chickens in Jiangsu, China.. Microbial Pathogenesis. 2025. DOI: https://doi.org/10.1016/j.micpath.2025.107394

[27] Kim S, Kim H, Noh Y, Won H, Hong S, Yoon I, et al.. Preclinical evaluation of a live avian metapneumovirus subtype B vaccine strain with cross-protective efficacy in chickens. Poultry Science. 2025. DOI: https://doi.org/10.1016/j.psj.2025.105283

[28] Lupini C, Gentile N, Graziosi G, Quaglia G, Lizzi G, Pedrazzoli S, et al.. Avian metapneumovirus subtype B in a Northern shoveler (Spatula clypeata) wintering in Italy: implications for the domestic-wild bird interface?. Avian Pathology. 2025. DOI: https://doi.org/10.1080/03079457.2024.2441175

[29] Wanarat S, Sukmak M, Soda N, Suwan P, Satayaphongpan N, Klinsawat W, et al.. Avian Metapneumovirus in Thailand: Molecular Detection, Genetic Diversity, and Its Potential Threat to Poultry. Viruses. 2025. DOI: https://doi.org/10.3390/v17070965

[30] Frye EM, Niel KR, Davison S, Lighty ME. Overview of Avian Metapneumovirus Outbreak in Pennsylvania.. Avian diseases. 2025. DOI: https://doi.org/10.1637/aviandiseases-d-25-00065

[31] Dong X, Zhang T, Liu L, Chen S, Li J, Zhang Y, et al.. Rapid field visual detection of avian metapneumovirus by integrating MIRA pre-amplification with CRISPR-Cas13a to enhance sensitivity and specificity: Innovative technologies well-suited for real-time large-scale epidemiological surveillance.. International Journal of Biological Macromolecules. 2025. DOI: https://doi.org/10.1016/j.ijbiomac.2025.144966

[32] Franzo G, Legnardi M, Faustini G, Baston R, Poletto F, Cecchinato M, et al.. Tracing the Flight: Investigating the Introduction of Avian Metapneumovirus (aMPV) A and B. Animals. 2024. DOI: https://doi.org/10.3390/ani14121786

[33] Salles G, Pilati GVT, Muniz EC, Neto AJdL, Vogt JR, Dahmer M, et al.. Trends and Challenges in the Surveillance and Control of Avian Metapneumovirus. Viruses. 2023. DOI: https://doi.org/10.3390/v15091960

[34] Kariithi H, Volkening J, Alves VV, Reis-Cunha J, Arantes L, Fernando FS, et al.. Complete Genome Sequences of Avian Metapneumovirus Subtype B Vaccine Strains from Brazil. Microbiology Resource Announcements. 2023. DOI: https://doi.org/10.1128/mra.00235-23

[35] Al-Mubarak AIA, Hussen J, Kandeel M, Al-Kubati AAG, Falemban B, Hemida MG. Evidence of the circulation of avian metapneumovirus in domestic backyard chickens in Eastern Saudi Arabia in 2019. Veterinary World. 2023. DOI: https://doi.org/10.14202/vetworld.2023.1246-1251

[36] Cho AY, Kim T, Lee S, Lee H, Choi Y, Seo Y, et al.. Whole genome sequencing of Avian metapneumovirus type B genomes directly from clinical samples collected from chickens in live bird markets using multiplex tiling RT-PCR method. Frontiers in Veterinary Science. 2023. DOI: https://doi.org/10.3389/fvets.2023.1112552

[37] Tucciarone C, Franzo G, Legnardi M, Pasotto D, Lupini C, Catelli E, et al.. Molecular Survey on A, B, C and New Avian Metapneumovirus (aMPV) Subtypes in Wild Birds of Northern-Central Italy. Veterinary Sciences. 2022. DOI: https://doi.org/10.3390/vetsci9070373

[38] Graziosi G, Lupini C, Catelli E. Disentangling the role of wild birds in avian metapneumovirus (aMPV) epidemiology: A systematic review and meta‐analysis. Transboundary and Emerging Diseases. 2022. DOI: https://doi.org/10.1111/tbed.14680

[39] Jesse ST, Ribó-Molina P, Jo W, Rautenschlein S, Vuong O, Fouchier R, et al.. Molecular characterization of avian metapneumovirus subtype C detected in wild mallards (Anas platyrhynchos) in The Netherlands.. Transboundary and Emerging Diseases. 2022. DOI: https://doi.org/10.1111/tbed.14688

[40] Lemaitre E, Bougeard S, Allée C, Eterradossi N, Courtillon C, Brown P. Avian metapneumovirus: A five-plex digital droplet RT-PCR method for identification of subgroups A, B, C, and D. Frontiers in Veterinary Science. 2022. DOI: https://doi.org/10.3389/fvets.2022.1058294

[41] Legnardi M, Allée C, Franzo G, Cecchinato M, Brown P. Research Note: Detection of Avian metapneumovirus subgroup C specific antibodies in a mallard flock in Italy. Poultry Science. 2021. DOI: https://doi.org/10.1016/J.PSJ.2021.101186

[42] Baston R, Tucciarone C, Franzo G, Legnardi M, Cecchinato M. A History of Neglect: Avian Metapneumovirus (aMPV) Epidemiology in Europe, the Middle East, and North Africa.. Avian diseases. 2026. DOI: https://doi.org/10.1637/aviandiseases-d-25-00076

[43] Franzo G, Legnardi M, Mescolini G, Tucciarone C, Lupini C, Quaglia G, et al.. Avian Metapneumovirus subtype B around Europe: a phylodynamic reconstruction. Veterinary Research. 2020. DOI: https://doi.org/10.1186/s13567-020-00817-6

[44] Andreopoulou M, Franzo G, Tucciarone C, Prentza Z, Koutoulis K, Cecchinato M, et al.. Molecular epidemiology of infectious bronchitis virus and avian metapneumovirus in Greece. Poultry Science. 2019. DOI: https://doi.org/10.3382/ps/pez360

[45] Yu M, Xing L, Chang F, Bao Y, Wang S, He X, et al.. Genomic sequence and pathogenicity of the first avian metapneumovirus subtype B isolated from chicken in China.. Veterinary Microbiology. 2019. DOI: https://doi.org/10.1016/j.vetmic.2018.11.009

[46] Ali MZ, Park J, Shin H. Serological Survey of Avian Metapneumovirus Infection in Chickens in Bangladesh. The Journal of Applied Poultry Research. 2019. DOI: https://doi.org/10.3382/japr/pfz050

[47] Youn H, Noh J, Kim M, Ju H, Park D, Lee D, et al.. Efficacy of a novel avian metapneumovirus live vaccine candidate based on vaccination route and age. Poultry Science. 2020. DOI: https://doi.org/10.1016/j.psj.2020.07.021

[48] A A, O. A, D O, O O. Serological survey for avian metapneumovirus in commercial chickens from different climatic zones in Nigeria. Journal of Veterinary Medicine and Animal Health. 2020. DOI: https://doi.org/10.5897/jvmah2020.0860

[49] Jardine C, Parmley EJ, Buchanan T, Nituch L, Ojkić D. Avian metapneumovirus subtype C in Wild Waterfowl in Ontario, Canada. Transboundary and Emerging Diseases. 2018. DOI: https://doi.org/10.1111/tbed.12832

[50] Baraa A, Alhatami AO, Muhsen H. The Effect of Vaccinated and Unvaccinated Bridles Flocks on Identification of Avian Metapneumovirus (aMPV) and Ornithobacteriumrhinotracheale (ORT) in the Middle Euphrates Region in Iraq. Medico-Legal Update. 2020. DOI: https://doi.org/10.37506/MLU.V20I4.1913

[51] Marzo E, Guirado E, Taberner E, Castanyer S, Teixidor I, Feu S. A new method for testing avian metapneumovirus vaccine efficacy: Evaluation of tracheal ciliary activity after a challenge.. Vaccine. 2025. DOI: https://doi.org/10.1016/j.vaccine.2025.127641

[52] Cea-Callejo P, Arca-Lafuente S, Gomez-Lucia E, Doménech A, Biarnés M, Blanco A, et al.. An affordable detection system based on RT-LAMP and DNA-nanoprobes for avian metapneumovirus. Applied Microbiology and Biotechnology. 2024. DOI: https://doi.org/10.1007/s00253-024-13243-x

[53] Loor-Giler A, Muslin C, Santander-Parra S, Coello D, Torre DIDl, Abad H, et al.. Simultaneous detection of infectious bronchitis virus and avian metapneumovirus genotypes A, B, and C by multiplex RT-qPCR assay in chicken tracheal samples in Ecuador. Frontiers in Veterinary Science. 2024. DOI: https://doi.org/10.3389/fvets.2024.1387172

[54] Bai Y, Wu X, Liu J, Wang Z, Dong M, Li T, et al.. Establishment and Application Prospect of Reverse Transcriptase Recombinase-Aided Amplification Assay for Subgroup C Avian Metapneumovirus. Veterinary Sciences. 2024. DOI: https://doi.org/10.3390/vetsci11030122

[55] Guo Y, Cheng J, Zhang S, Zhang Y, Zuo Y, Liu T, et al.. Recombinant avian metapneumovirus subtype C expressing HA protein of H9N2 avian influenza virus are stable and induce protection. Frontiers in Microbiology. 2024. DOI: https://doi.org/10.3389/fmicb.2024.1513474

[56] El-Ghany WAA. Avian Metapneumovirus Infection in Poultry Flocks: A Review of Current Knowledge. Pertanika Journal of Tropical Agricultural Science. 2023. DOI: https://doi.org/10.47836/pjtas.46.3.14

[57] Tegegne D, Deneke Y, Sori T, Abdurahaman M, Kebede N, Cecchinato M, et al.. Molecular Epidemiology and Genotyping of Infectious Bronchitis Virus and Avian Metapneumovirus in Backyard and Commercial Chickens in Jimma Zone, Southwestern Ethiopia. Veterinary Sciences. 2020. DOI: https://doi.org/10.3390/vetsci7040187

[58] Escobar-Alfonso S, Álvarez-Mira D, Beltran-Leon M, Ramírez-Nieto G, Gomez AP. Avian Metapneumovirus Subtype B Circulation in Poultry and Wild Birds of Colombia. Pathogens. 2024. DOI: https://doi.org/10.3390/pathogens13100882

[59] Baston R, Tucciarone C, Caudullo A, Poletto F, Legnardi M, Cecchinato M, et al.. Molecular Epidemiology of Beak and Feather Disease Virus (BFDV), Avian Polyomavirus (APV-1), Psittacid Herpesvirus 1 (PsHV-1), and Avian Metapneumovirus (aMPV) in Birds Kept as Non-Traditional Companion Animals (NTCAs) in Italy. Animals. 2025. DOI: https://doi.org/10.3390/ani15152164

[60] Mo J, Briggs K, Sweeney R, Parker M, Carlson J, Suarez DL, et al.. Lack of Avian Metapneumovirus Detection of Subtypes A and B in Eggs from Virus-Positive Commercial Turkey Breeders Supports the Premise That Vertical Transmission Does Not Contribute to Virus Spread.. Avian diseases. 2025. DOI: https://doi.org/10.1637/aviandiseases-d-25-00039

[61] Lupini C, Legnardi M, Graziosi G, Cecchinato M, Listorti V, Terregino C, et al.. Vaccine Interaction and Protection against Virulent Avian Metapneumovirus (aMPV) Challenge after Combined Administration of Newcastle Disease and aMPV Live Vaccines to Day-Old Turkeys. Vaccines. 2023. DOI: https://doi.org/10.3390/vaccines11030708

[62] Bao Y, Yu M, Liu P, Hou F, Muhammad F, Wang Z, et al.. Novel Inactivated Subtype B Avian Metapneumovirus Vaccine Induced Humoral and Cellular Immune Responses. Vaccines. 2020. DOI: https://doi.org/10.3390/vaccines8040762